exenatide's tag archives

Exenatide Once Weekly Provided Superior Glucose Control Compared To Lantus in Head-to-Head DURATION-3 Study

Posted by Dana in July 21st 2009

Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN), Eli Lilly and Company (NYSE: LLY) and Alkermes, Inc. (Nasdaq: ALKS) announced positive results from a study comparing subjects randomized to either exenatide once weekly or Lantus (insulin glargine). Patients randomized to exenatide once weekly experienced a statistically superior reduction in A1C, a measure of average blood sugar over three [...]

Continue reading " Exenatide Once Weekly Provided Superior Glucose Control Compared To Lantus in Head-to-Head DURATION-3 Study "

New Drug Application for Exenatide Once Weekly Accepted for Review by FDA

Posted by Dana in July 8th 2009

Amylin Pharmaceuticals, Inc., (Nasdaq: AMLN), Eli Lilly and Company (NYSE: LLY) and Alkermes, Inc. (Nasdaq: ALKS) announced that the New Drug Application (NDA) for exenatide once weekly has been accepted for review by the U.S. Food and Drug Administration (FDA). Related posts diabetes?? (9) Lastest Diabetes News (0) Array BioPharma Reports Financial Results for the [...]

Continue reading " New Drug Application for Exenatide Once Weekly Accepted for Review by FDA "

No Comment

under: FDA Approval
Tags: Diabetes, exenatide